Argatroban | Pfizer | ||
1 mg/ml, 100 mg/ml; Injection, Injectable |
Less Than $1000 mn
|
||
Less Than 5
|
Less Than 5
|
||
Less Than 5
|
Less Than 5
|
||
More Than 5
|
Less Than 5
|
||
Used in treatment of thrombosis in adults with heparin-induced thrombocytopenia (HIT). | |||
Yes
|
Argatroban | Patent 1 | Patent 2 |
---|---|---|
****** (*****) | ||
****** ***** ************ |
Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
---|---|---|---|---|---|
****** (*****) | |||||
****** ***** ************ | **** ****** **** |